To better compare belimumab’s efficacy with results from phase 3 trials of obinutuzumab, investigators conducted a post hoc analysis of patients with active proliferative lupus nephritis in the MMF ...

Patients who develop LN within 1 to 5 years after SLE onset may face poorer renal outcomes compared with those who develop the disease earlier.

Negotiated reliance may offer a way to provide care to patients who resist efforts by clinicians and healthcare facilities.

A subset of patients receiving triple immunosuppressive therapy with voclosporin, mycophenolate mofetil, and low-dose glucocorticoids can achieve lower proteinuria targets.

The FDA has approved HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.

Investigators aimed to identify an optimal PSA cut-off to define PSA persistence after prostate cancer surgery using new ultrasensitive assay methods.

The FDA has granted Orphan Drug designation to NS-229 for the treatment of eosinophilic granulomatosis with polyangiitis.

These changes are meant to limit the use of the shots while experts collect more data on how well they work for healthy people.

New research suggests that outpatients with cancer are more likely than other outpatients to have antimicrobial-resistant bacterial pathogens.

Investigators present 48 month follow-up data from a phase 2b trial on padeliporfin vascular-targeted photodynamic therapy for intermediate-risk prostate cancer.

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...